Peer-influenced content. Sources you trust. No registration required. This is HCN.
Conexiant
A Swedish national cohort analysis linked bereavement to elevated incident cardiovascular disease risk before and during the COVID-19 pandemic, with the strongest pandemic-period association following partner loss.
Cardiology May 19th 2026
Hematology Advisor
A SARS-CoV-2 variant designated BA.3.2, or “Cicada,” has been added to the WHO variants under monitoring list, with wastewater detection across at least 25 US states and 132 locations.
Emergency Medicine May 8th 2026
Cancer Therapy Advisor
The current real-world cohort study examines long-term survival outcomes in the 5 years after a COVID-19 hospitalization for adults with a solid malignancy. The study assessed the impact of vaccination status, vaccine platform, primary tumor site, and cancer treatment.
Oncology, Medical April 14th 2026
Annals of Internal Medicine
“Fluvoxamine may have a beneficial role in the clinical management of fatigue in long COVID, although the condition encompasses a broad range of clinical manifestations beyond fatigue alone.” — REVIVE Trial, Annals of Internal Medicine
Hospitalist April 10th 2026
Infectious Disease Advisor
Genomic analyses revealed that all circulating strains were descendants of the Omicron JN.1 variant, “representing the first season without a SARS-CoV-2 strain replacement since the beginning of the COVID-19 pandemic.”
Family Medicine/General Practice March 12th 2026
Epoch Health
Dr. Joseph Wu, the study’s lead author and director of the Stanford Cardiovascular Institute: “These two cytokines cause inflammation to the blood vessels. They could cause inflammation to the heart.”
Cardiology January 14th 2026